- Cholesterol-lowering drug gets US approval NEWS.com.au
- New Lipid-Lowering Drug Earns FDA Approval Medscape
- Esperion scores FDA nod for cholesterol-buster Nexletol FiercePharma
- FDA Approves New Lipid-Lowering Drug, Bempedoic Acid TCTMD
- Cholesterol Medicine: Biotech Company Esperion Nabs Key Approval Investor's Business Daily
- View Full coverage on Google News
